G

GI PROS, Inc. | Naples, FL

Research site

(Unclaimed)

Location

1080 Goodlette Road, Naples, Florida, United States of America

Site insights

Top conditions

Top treatments

TAK-279

REC-4881

Vedolizumab

Upadacitinib

Amlitelimab

CREON

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 7 total trials

Locations recently updated

A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease

This is a Phase 2a/b, randomized, double-blind, placebo-controlled, parallel-group, 6-arm study to evaluate the efficacy and safety of amlitelimab in...

Enrolling

Coeliac Disease

Celiac Disease

Dietary Supplement: SIGE

Drug: Placebo

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease (VICTRIVA)

The main aim of this study is to learn whether vedolizumab and upadacitinib given together (also called dual targeted therapy or DTT) reduces bowel i...

Enrolling

Crohn's Disease

Drug: Vedolizumab

Drug: Placebo

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate t...

Enrolling

Crohn's Disease

Drug: Placebo

Drug: TAK-279

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

The main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical...

Enrolling

Ulcerative Colitis

Drug: TAK-279

Drug: Placebo